MARKET

SELB

SELB

Selecta
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.320
+0.180
+5.73%
After Hours: 3.320 0 0.00% 16:00 01/17 EST
OPEN
3.160
PREV CLOSE
3.140
HIGH
3.340
LOW
3.100
VOLUME
721.74K
TURNOVER
--
52 WEEK HIGH
3.500
52 WEEK LOW
1.280
MARKET CAP
160.01M
P/E (TTM)
-2.0874
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SELB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SELB News

  • The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
  • Benzinga.1d ago
  • APA, ADXS, KODK, and PACD among midday movers
  • Seeking Alpha - Article.01/07 17:41
  • RAD, INO, MDR and ASNA among midday movers
  • Seeking Alpha - Article.12/19/2019 17:43
  • Selecta Biosciences out-licenses ImmTOR to Asklepios BioPharmaceutical
  • Seeking Alpha - Article.12/19/2019 14:26

More

Industry

Biotechnology & Medical Research
-0.10%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About SELB

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are designed to modulate the immune system to treat rare and serious diseases. The Company is engaged in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its product candidates are in various stages of clinical and preclinical development. Its SVP technology encapsulates an immunomodulator in biodegradable nanoparticles to induce antigen-specific immune tolerance to mitigate the formation of anti-drug antibodies (ADAs) in response to life-sustaining biologic drugs. The Company's lead product candidate, SEL-212, is a combination of a therapeutic enzyme and its SVP technology designed to be the biologic treatment for gout.
More

Webull offers Selecta Biosciences Inc (SELB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.